The abstract is read at the publisher; the summary is JClub's.
In 1,356 Framingham Heart Study participants without diabetes, higher CGM % time >140 mg/dL (15.4%) is linked to greater 10-year CVD risk and higher odds of hypertension and dyslipidemia.
- Why it matters: Fasting plasma glucose and HbA1c may miss dysglycemia heterogeneity, limiting how well cardiometabolic risk factors are identified in people without diabetes.
- What they did: Participants wore blinded Dexcom G6 Pro CGM for up to 10 days; researchers used glycemic burden/variability classification and unsupervised clustering, then ran multivariable linear and logistic regression against PREVENT 10-year CVD risk and individual CMRFs.
- The result: CGM-derived profiles indicating higher dysglycemia showed discordance with traditional glycemic status and, for those overlapping traditionally defined prediabetes, were associated with 6–7% higher 10-year CVD risk estimates plus worse CMRFs.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.